ID   DYRK2_HUMAN             Reviewed;         601 AA.
AC   Q92630; B2R9V9; Q9BRB5;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 3.
DT   05-OCT-2010, entry version 108.
DE   RecName: Full=Dual specificity tyrosine-phosphorylation-regulated kinase 2;
DE            EC=2.7.12.1;
GN   Name=DYRK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, COFACTOR,
RP   PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   MEDLINE=98421512; PubMed=9748265; DOI=10.1074/jbc.273.40.25893;
RA   Becker W., Weber Y., Wetzel K., Eirmbter K., Tejedor F.J.,
RA   Joost H.-G.;
RT   "Sequence characteristics, subcellular localization, and substrate
RT   specificity of DYRK-related kinases, a novel family of dual
RT   specificity protein kinases.";
RL   J. Biol. Chem. 273:25893-25902(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 320-528 (ISOFORMS 1/2).
RC   TISSUE=Placenta;
RA   Becker W., Joost H.-G.;
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION.
RX   PubMed=11311121;
RA   Woods Y.L., Cohen P., Becker W., Jakes R., Goedert M., Wang X.,
RA   Proud C.G.;
RT   "The kinase DYRK phosphorylates protein-synthesis initiation factor
RT   eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at
RT   Thr212: potential role for DYRK as a glycogen synthase kinase 3-
RT   priming kinase.";
RL   Biochem. J. 355:609-615(2001).
RN   [7]
RP   FUNCTION.
RX   PubMed=14593110; DOI=10.1074/jbc.M301769200;
RA   Skurat A.V., Dietrich A.D.;
RT   "Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family
RT   protein kinases.";
RL   J. Biol. Chem. 279:2490-2498(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-382, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17349958; DOI=10.1016/j.molcel.2007.02.007;
RA   Taira N., Nihira K., Yamaguchi T., Miki Y., Yoshida K.;
RT   "DYRK2 is targeted to the nucleus and controls p53 via Ser46
RT   phosphorylation in the apoptotic response to DNA damage.";
RL   Mol. Cell 25:725-738(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-382, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 146-552 IN COMPLEX WITH
RP   INDIRUBIN.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of dual-specificity tyrosine phosphorylation
RT   regulated kinase 2 (DYRK2) in complex with an indirubin ligand.";
RL   Submitted (JAN-2010) to the PDB data bank.
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-98; LEU-198; ASN-245; SER-295;
RP   GLN-451 AND TYR-455.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Role in the regulation of cellular growth and/or
CC       development. Regulates TP53 by phosphorylation on Ser-46 to induce
CC       apoptosis in response to DNA damage, functioning downstream of
CC       ATM. Inactivates GYS1 by phosphorylation at Ser-641, and
CC       potentially also a second phosphorylation site, thus regulating
CC       glycogen synthesis. Phosphorylates EIF2B5 at Ser-544, enabling its
CC       subsequent phosphorylation and inhibition by GSK3, and may play a
CC       more general role in the priming of GSK3 substrates.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- COFACTOR: Manganese.
CC   -!- ENZYME REGULATION: Autophosphorylates on tyrosine residues.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Translocates into
CC       the nucleus following DNA damage.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92630-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92630-2; Sequence=VSP_026115;
CC   -!- TISSUE SPECIFICITY: Testis, after the onset of spermatogenesis.
CC   -!- PTM: Phosphorylated on serine/threonine residues (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MNB/DYRK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA73885.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y13493; CAA73885.1; ALT_INIT; mRNA.
DR   EMBL; AK313937; BAG36656.1; -; mRNA.
DR   EMBL; CH471054; EAW97176.1; -; Genomic_DNA.
DR   EMBL; BC005809; AAH05809.1; -; mRNA.
DR   EMBL; BC006375; AAH06375.1; -; mRNA.
DR   EMBL; Y09216; CAA70418.1; -; mRNA.
DR   IPI; IPI00022521; -.
DR   IPI; IPI00304942; -.
DR   RefSeq; NP_003574.1; -.
DR   RefSeq; NP_006473.2; -.
DR   UniGene; Hs.173135; -.
DR   PDB; 3K2L; X-ray; 2.36 A; A=146-552.
DR   PDB; 3KVW; X-ray; 2.28 A; A=146-552.
DR   PDBsum; 3K2L; -.
DR   PDBsum; 3KVW; -.
DR   ProteinModelPortal; Q92630; -.
DR   IntAct; Q92630; 1.
DR   MINT; MINT-1469581; -.
DR   STRING; Q92630; -.
DR   PhosphoSite; Q92630; -.
DR   PRIDE; Q92630; -.
DR   Ensembl; ENST00000344096; ENSP00000342105; ENSG00000127334.
DR   GeneID; 8445; -.
DR   KEGG; hsa:8445; -.
DR   UCSC; uc001str.2; human.
DR   UCSC; uc001sts.2; human.
DR   CTD; 8445; -.
DR   GeneCards; GC12P068042; -.
DR   H-InvDB; HIX0010797; -.
DR   HGNC; HGNC:3093; DYRK2.
DR   HPA; HPA027230; -.
DR   MIM; 603496; gene.
DR   PharmGKB; PA27550; -.
DR   eggNOG; prNOG17639; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG051426; -.
DR   InParanoid; Q92630; -.
DR   OMA; QVPHDHV; -.
DR   OrthoDB; EOG9909W7; -.
DR   PhylomeDB; Q92630; -.
DR   BRENDA; 2.7.12.1; 247.
DR   NextBio; 31596; -.
DR   ArrayExpress; Q92630; -.
DR   Bgee; Q92630; -.
DR   CleanEx; HS_DYRK2; -.
DR   Genevestigator; Q92630; -.
DR   GermOnline; ENSG00000127334; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0042771; P:DNA damage response, signal transduction by...; IDA:UniProtKB.
DR   GO; GO:0045725; P:positive regulation of glycogen biosyntheti...; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Complete proteome; Cytoplasm; Kinase; Magnesium; Manganese;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    601       Dual specificity tyrosine-
FT                                phosphorylation-regulated kinase 2.
FT                                /FTId=PRO_0000085936.
FT   DOMAIN      222    535       Protein kinase.
FT   NP_BIND     228    236       ATP (By similarity).
FT   ACT_SITE    348    348       Proton acceptor (By similarity).
FT   BINDING     251    251       ATP (By similarity).
FT   MOD_RES     382    382       Phosphotyrosine.
FT   VAR_SEQ       1     73       Missing (in isoform 2).
FT                                /FTId=VSP_026115.
FT   VARIANT      98     98       S -> G (in dbSNP:rs35139851).
FT                                /FTId=VAR_040458.
FT   VARIANT     198    198       P -> L (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040459.
FT   VARIANT     245    245       H -> N (in dbSNP:rs34166200).
FT                                /FTId=VAR_040460.
FT   VARIANT     295    295       N -> S (in dbSNP:rs56293072).
FT                                /FTId=VAR_040461.
FT   VARIANT     451    451       R -> Q (in dbSNP:rs35688869).
FT                                /FTId=VAR_040462.
FT   VARIANT     455    455       F -> Y (in dbSNP:rs55774594).
FT                                /FTId=VAR_040463.
FT   STRAND      149    152
FT   HELIX       156    163
FT   HELIX       164    166
FT   HELIX       169    174
FT   HELIX       175    177
FT   TURN        219    221
FT   STRAND      222    227
FT   STRAND      236    241
FT   TURN        242    245
FT   STRAND      246    252
FT   HELIX       257    274
FT   STRAND      287    293
FT   STRAND      296    301
FT   HELIX       309    314
FT   TURN        315    317
FT   HELIX       322    342
FT   HELIX       351    353
FT   HELIX       386    388
FT   HELIX       391    394
FT   HELIX       402    407
FT   HELIX       411    416
FT   HELIX       430    437
FT   HELIX       443    447
FT   HELIX       452    455
FT   HELIX       506    515
FT   TURN        520    522
FT   TURN        533    535
SQ   SEQUENCE   601 AA;  66652 MW;  A7BEE25CDF944436 CRC64;
     MLTRKPSAAA PAAYPTGRGG DSAVRQLQAS PGLGAGATRS GVGTGPPSPI ALPPLRASNA
     AAAAHTIGGS KHTMNDHLHV GSHAHGQIQV QQLFEDNSNK RTVLTTQPNG LTTVGKTGLP
     VVPERQLDSI HRRQGSSTSL KSMEGMGKVK ATPMTPEQAM KQYMQKLTAF EHHEIFSYPE
     IYFLGLNAKK RQGMTGGPNN GGYDDDQGSY VQVPHDHVAY RYEVLKVIGK GSFGQVVKAY
     DHKVHQHVAL KMVRNEKRFH RQAAEEIRIL EHLRKQDKDN TMNVIHMLEN FTFRNHICMT
     FELLSMNLYE LIKKNKFQGF SLPLVRKFAH SILQCLDALH KNRIIHCDLK PENILLKQQG
     RSGIKVIDFG SSCYEHQRVY TYIQSRFYRA PEVILGARYG MPIDMWSLGC ILAELLTGYP
     LLPGEDEGDQ LACMIELLGM PSQKLLDASK RAKNFVSSKG YPRYCTVTTL SDGSVVLNGG
     RSRRGKLRGP PESREWGNAL KGCDDPLFLD FLKQCLEWDP AVRMTPGQAL RHPWLRRRLP
     KPPTGEKTSV KRITESTGAI TSISKLPPPS SSASKLRTNL AQMTDANGNI QQRTVLPKLV
     S
//
